Global Indocyanine Green for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Indocyanine Green for Injection market size was valued at US$ 92.19 million in 2025 and is forecast to a readjusted size of US$ 151 million by 2032 with a CAGR of 7.0% during review period.
Indocyanine Green for Injection is a sterile injectable diagnostic drug with indocyanine green as the active ingredient, typically supplied as a 25 mg lyophilized powder for injection or a solvent-combined package. It is mainly used for liver function and hepatic blood flow assessment, ophthalmic choroidal angiography, tissue perfusion assessment, biliary visualization, lymphatic tracing, sentinel lymph node mapping and fluorescence-guided surgery. Key upstream materials include pharmaceutical-grade indocyanine green API, formulation excipients such as sodium iodide, water for injection, sterile vials, rubber stoppers, aluminum-plastic caps, lyophilized formulation packaging materials, light-protective packaging materials, and quality control consumables for sterility testing, assay testing and impurity control. Major downstream customers include general hospitals, ophthalmic specialty hospitals, hepatobiliary surgery departments, gastrointestinal surgery departments, oncology surgery departments, vascular surgery departments, transplant centers, breast surgery departments, ambulatory surgery centers and pharmaceutical distributors. On an ex-factory finished-formulation basis, global production capacity in 2025 is estimated at about 1.80 million units, with sales volume of approximately 1.127 million units, an average ex-factory price of around USD 79.5 per unit and an industry gross margin range of approximately 52%–68%. The product is a low-volume, high-value diagnostic drug with strong regulatory attributes, and its manufacturing requires strict aseptic processing, lyophilization control, visible particulate control, assay and impurity testing, sterility assurance and stability management.
The market for Indocyanine Green for Injection remains a low-volume but high-value specialty diagnostic drug segment, with demand mainly driven by ophthalmic angiography, liver function and blood flow assessment, tissue perfusion evaluation, biliary visualization, lymphatic tracing and fluorescence-guided surgery. As minimally invasive surgery, oncology surgery, hepatobiliary surgery and breast surgery increasingly require real-time intraoperative visualization, ICG is evolving from a conventional diagnostic drug into a combined diagnostic and surgical navigation agent. Given the high requirements for aseptic lyophilization, stability, impurity control and regulatory compliance, the number of qualified finished-product manufacturers remains limited, and the supply structure is still specialized and regionally concentrated.
Future growth will be closely linked to the penetration of fluorescence imaging systems, endoscopic platforms, surgical robots and intraoperative navigation solutions. ICG itself is not an equipment product, but its clinical consumption is highly correlated with the installed base of fluorescence imaging systems, procedural adoption by surgeons and hospital clinical pathways. As more hospitals use fluorescence guidance for biliary imaging, lymph node mapping, perfusion assessment and tumor margin identification, the application base of Indocyanine Green for Injection is expected to expand further. Compared with traditional ophthalmic and liver-function diagnostic use, intraoperative visualization is likely to contribute more to value growth and procedural demand.
From a competitive perspective, the U.S., European and Japanese markets are mainly supported by branded formulations, established regulatory pathways and mature hospital channels, with relatively higher pricing. In China, the approval and promotion of domestic products are driving both import substitution and pricing pressure. Although the product has a relatively high unit value, the total market size remains limited, and new entrants must have capabilities in raw material quality control, aseptic lyophilized formulation production, stable supply and clinical registration. As a result, the market is unlikely to quickly become a broad commodity generics market, and leading suppliers will continue to rely on regulatory approvals, brand recognition, supply reliability and indication coverage.
Key constraints include regulatory approval requirements, clinical-use standardization, regional price differences and the evolution of alternative technologies. Indications, dosing practices, packaging requirements and clinical-use boundaries vary across countries, which increases the complexity of global registration and commercialization. In addition, dye-free imaging technologies, enhanced imaging algorithms and next-generation fluorescent probes may act as substitutes or complements in selected use cases. However, given its safety profile, cost-effectiveness, physician familiarity and accumulated clinical evidence, Indocyanine Green for Injection is expected to remain one of the most mature and accessible tracer drugs for fluorescence-guided procedures and clinical perfusion assessment in the near to medium term.
This report is a detailed and comprehensive analysis for global Indocyanine Green for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Indocyanine Green for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Indocyanine Green for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Indocyanine Green for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Indocyanine Green for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Indocyanine Green for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Indocyanine Green for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Indocyanine Green for Injection, with price, sales quantity, revenue, and global market share of Indocyanine Green for Injection from 2021 to 2026.
Chapter 3, the Indocyanine Green for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Indocyanine Green for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Indocyanine Green for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Indocyanine Green for Injection.
Chapter 14 and 15, to describe Indocyanine Green for Injection sales channel, distributors, customers, research findings and conclusion.
Indocyanine Green for Injection is a sterile injectable diagnostic drug with indocyanine green as the active ingredient, typically supplied as a 25 mg lyophilized powder for injection or a solvent-combined package. It is mainly used for liver function and hepatic blood flow assessment, ophthalmic choroidal angiography, tissue perfusion assessment, biliary visualization, lymphatic tracing, sentinel lymph node mapping and fluorescence-guided surgery. Key upstream materials include pharmaceutical-grade indocyanine green API, formulation excipients such as sodium iodide, water for injection, sterile vials, rubber stoppers, aluminum-plastic caps, lyophilized formulation packaging materials, light-protective packaging materials, and quality control consumables for sterility testing, assay testing and impurity control. Major downstream customers include general hospitals, ophthalmic specialty hospitals, hepatobiliary surgery departments, gastrointestinal surgery departments, oncology surgery departments, vascular surgery departments, transplant centers, breast surgery departments, ambulatory surgery centers and pharmaceutical distributors. On an ex-factory finished-formulation basis, global production capacity in 2025 is estimated at about 1.80 million units, with sales volume of approximately 1.127 million units, an average ex-factory price of around USD 79.5 per unit and an industry gross margin range of approximately 52%–68%. The product is a low-volume, high-value diagnostic drug with strong regulatory attributes, and its manufacturing requires strict aseptic processing, lyophilization control, visible particulate control, assay and impurity testing, sterility assurance and stability management.
The market for Indocyanine Green for Injection remains a low-volume but high-value specialty diagnostic drug segment, with demand mainly driven by ophthalmic angiography, liver function and blood flow assessment, tissue perfusion evaluation, biliary visualization, lymphatic tracing and fluorescence-guided surgery. As minimally invasive surgery, oncology surgery, hepatobiliary surgery and breast surgery increasingly require real-time intraoperative visualization, ICG is evolving from a conventional diagnostic drug into a combined diagnostic and surgical navigation agent. Given the high requirements for aseptic lyophilization, stability, impurity control and regulatory compliance, the number of qualified finished-product manufacturers remains limited, and the supply structure is still specialized and regionally concentrated.
Future growth will be closely linked to the penetration of fluorescence imaging systems, endoscopic platforms, surgical robots and intraoperative navigation solutions. ICG itself is not an equipment product, but its clinical consumption is highly correlated with the installed base of fluorescence imaging systems, procedural adoption by surgeons and hospital clinical pathways. As more hospitals use fluorescence guidance for biliary imaging, lymph node mapping, perfusion assessment and tumor margin identification, the application base of Indocyanine Green for Injection is expected to expand further. Compared with traditional ophthalmic and liver-function diagnostic use, intraoperative visualization is likely to contribute more to value growth and procedural demand.
From a competitive perspective, the U.S., European and Japanese markets are mainly supported by branded formulations, established regulatory pathways and mature hospital channels, with relatively higher pricing. In China, the approval and promotion of domestic products are driving both import substitution and pricing pressure. Although the product has a relatively high unit value, the total market size remains limited, and new entrants must have capabilities in raw material quality control, aseptic lyophilized formulation production, stable supply and clinical registration. As a result, the market is unlikely to quickly become a broad commodity generics market, and leading suppliers will continue to rely on regulatory approvals, brand recognition, supply reliability and indication coverage.
Key constraints include regulatory approval requirements, clinical-use standardization, regional price differences and the evolution of alternative technologies. Indications, dosing practices, packaging requirements and clinical-use boundaries vary across countries, which increases the complexity of global registration and commercialization. In addition, dye-free imaging technologies, enhanced imaging algorithms and next-generation fluorescent probes may act as substitutes or complements in selected use cases. However, given its safety profile, cost-effectiveness, physician familiarity and accumulated clinical evidence, Indocyanine Green for Injection is expected to remain one of the most mature and accessible tracer drugs for fluorescence-guided procedures and clinical perfusion assessment in the near to medium term.
This report is a detailed and comprehensive analysis for global Indocyanine Green for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Indocyanine Green for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Indocyanine Green for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Indocyanine Green for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Indocyanine Green for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Indocyanine Green for Injection
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Indocyanine Green for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 25 mg/Vial
- 50 mg/Vial
- Hepatobiliary and Gastrointestinal Surgery
- Oncology Surgery
- Vascular and Transplant Surgery
- Ophthalmology
- Others
- Hospitals
- Specialty Clinics
- Other
- Diagnostic Green
- Daiichi Sankyo
- Nanjing Chia Tai Tianqing Pharmaceutical
- Dandong Yichuang Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Indocyanine Green for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Indocyanine Green for Injection, with price, sales quantity, revenue, and global market share of Indocyanine Green for Injection from 2021 to 2026.
Chapter 3, the Indocyanine Green for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Indocyanine Green for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Indocyanine Green for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Indocyanine Green for Injection.
Chapter 14 and 15, to describe Indocyanine Green for Injection sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Indocyanine Green for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 25 mg/Vial
1.3.3 50 mg/Vial
1.4 Market Analysis by End-use Department
1.4.1 Overview: Global Indocyanine Green for Injection Consumption Value by End-use Department: 2021 Versus 2025 Versus 2032
1.4.2 Hepatobiliary and Gastrointestinal Surgery
1.4.3 Oncology Surgery
1.4.4 Vascular and Transplant Surgery
1.4.5 Ophthalmology
1.4.6 Others
1.5 Market Analysis by Application
1.5.1 Overview: Global Indocyanine Green for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Other
1.6 Global Indocyanine Green for Injection Market Size & Forecast
1.6.1 Global Indocyanine Green for Injection Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Indocyanine Green for Injection Sales Quantity (2021-2032)
1.6.3 Global Indocyanine Green for Injection Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Diagnostic Green
2.1.1 Diagnostic Green Details
2.1.2 Diagnostic Green Major Business
2.1.3 Diagnostic Green Indocyanine Green for Injection Product and Services
2.1.4 Diagnostic Green Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Diagnostic Green Recent Developments/Updates
2.2 Daiichi Sankyo
2.2.1 Daiichi Sankyo Details
2.2.2 Daiichi Sankyo Major Business
2.2.3 Daiichi Sankyo Indocyanine Green for Injection Product and Services
2.2.4 Daiichi Sankyo Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Daiichi Sankyo Recent Developments/Updates
2.3 Nanjing Chia Tai Tianqing Pharmaceutical
2.3.1 Nanjing Chia Tai Tianqing Pharmaceutical Details
2.3.2 Nanjing Chia Tai Tianqing Pharmaceutical Major Business
2.3.3 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
2.3.4 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
2.4 Dandong Yichuang Pharmaceutical
2.4.1 Dandong Yichuang Pharmaceutical Details
2.4.2 Dandong Yichuang Pharmaceutical Major Business
2.4.3 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
2.4.4 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Dandong Yichuang Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INDOCYANINE GREEN FOR INJECTION BY MANUFACTURER
3.1 Global Indocyanine Green for Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Indocyanine Green for Injection Revenue by Manufacturer (2021-2026)
3.3 Global Indocyanine Green for Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Indocyanine Green for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Indocyanine Green for Injection Manufacturer Market Share in 2025
3.4.3 Top 6 Indocyanine Green for Injection Manufacturer Market Share in 2025
3.5 Indocyanine Green for Injection Market: Overall Company Footprint Analysis
3.5.1 Indocyanine Green for Injection Market: Region Footprint
3.5.2 Indocyanine Green for Injection Market: Company Product Type Footprint
3.5.3 Indocyanine Green for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Indocyanine Green for Injection Market Size by Region
4.1.1 Global Indocyanine Green for Injection Sales Quantity by Region (2021-2032)
4.1.2 Global Indocyanine Green for Injection Consumption Value by Region (2021-2032)
4.1.3 Global Indocyanine Green for Injection Average Price by Region (2021-2032)
4.2 North America Indocyanine Green for Injection Consumption Value (2021-2032)
4.3 Europe Indocyanine Green for Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Indocyanine Green for Injection Consumption Value (2021-2032)
4.5 South America Indocyanine Green for Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Indocyanine Green for Injection Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
5.2 Global Indocyanine Green for Injection Consumption Value by Type (2021-2032)
5.3 Global Indocyanine Green for Injection Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
6.2 Global Indocyanine Green for Injection Consumption Value by Application (2021-2032)
6.3 Global Indocyanine Green for Injection Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
7.2 North America Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
7.3 North America Indocyanine Green for Injection Market Size by Country
7.3.1 North America Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
7.3.2 North America Indocyanine Green for Injection Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
8.2 Europe Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
8.3 Europe Indocyanine Green for Injection Market Size by Country
8.3.1 Europe Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
8.3.2 Europe Indocyanine Green for Injection Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Indocyanine Green for Injection Market Size by Region
9.3.1 Asia-Pacific Indocyanine Green for Injection Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Indocyanine Green for Injection Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
10.2 South America Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
10.3 South America Indocyanine Green for Injection Market Size by Country
10.3.1 South America Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
10.3.2 South America Indocyanine Green for Injection Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Indocyanine Green for Injection Market Size by Country
11.3.1 Middle East & Africa Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Indocyanine Green for Injection Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Indocyanine Green for Injection Market Drivers
12.2 Indocyanine Green for Injection Market Restraints
12.3 Indocyanine Green for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Indocyanine Green for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Indocyanine Green for Injection
13.3 Indocyanine Green for Injection Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Indocyanine Green for Injection Typical Distributors
14.3 Indocyanine Green for Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Indocyanine Green for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 25 mg/Vial
1.3.3 50 mg/Vial
1.4 Market Analysis by End-use Department
1.4.1 Overview: Global Indocyanine Green for Injection Consumption Value by End-use Department: 2021 Versus 2025 Versus 2032
1.4.2 Hepatobiliary and Gastrointestinal Surgery
1.4.3 Oncology Surgery
1.4.4 Vascular and Transplant Surgery
1.4.5 Ophthalmology
1.4.6 Others
1.5 Market Analysis by Application
1.5.1 Overview: Global Indocyanine Green for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Other
1.6 Global Indocyanine Green for Injection Market Size & Forecast
1.6.1 Global Indocyanine Green for Injection Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Indocyanine Green for Injection Sales Quantity (2021-2032)
1.6.3 Global Indocyanine Green for Injection Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Diagnostic Green
2.1.1 Diagnostic Green Details
2.1.2 Diagnostic Green Major Business
2.1.3 Diagnostic Green Indocyanine Green for Injection Product and Services
2.1.4 Diagnostic Green Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Diagnostic Green Recent Developments/Updates
2.2 Daiichi Sankyo
2.2.1 Daiichi Sankyo Details
2.2.2 Daiichi Sankyo Major Business
2.2.3 Daiichi Sankyo Indocyanine Green for Injection Product and Services
2.2.4 Daiichi Sankyo Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Daiichi Sankyo Recent Developments/Updates
2.3 Nanjing Chia Tai Tianqing Pharmaceutical
2.3.1 Nanjing Chia Tai Tianqing Pharmaceutical Details
2.3.2 Nanjing Chia Tai Tianqing Pharmaceutical Major Business
2.3.3 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
2.3.4 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
2.4 Dandong Yichuang Pharmaceutical
2.4.1 Dandong Yichuang Pharmaceutical Details
2.4.2 Dandong Yichuang Pharmaceutical Major Business
2.4.3 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
2.4.4 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Dandong Yichuang Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INDOCYANINE GREEN FOR INJECTION BY MANUFACTURER
3.1 Global Indocyanine Green for Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Indocyanine Green for Injection Revenue by Manufacturer (2021-2026)
3.3 Global Indocyanine Green for Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Indocyanine Green for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Indocyanine Green for Injection Manufacturer Market Share in 2025
3.4.3 Top 6 Indocyanine Green for Injection Manufacturer Market Share in 2025
3.5 Indocyanine Green for Injection Market: Overall Company Footprint Analysis
3.5.1 Indocyanine Green for Injection Market: Region Footprint
3.5.2 Indocyanine Green for Injection Market: Company Product Type Footprint
3.5.3 Indocyanine Green for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Indocyanine Green for Injection Market Size by Region
4.1.1 Global Indocyanine Green for Injection Sales Quantity by Region (2021-2032)
4.1.2 Global Indocyanine Green for Injection Consumption Value by Region (2021-2032)
4.1.3 Global Indocyanine Green for Injection Average Price by Region (2021-2032)
4.2 North America Indocyanine Green for Injection Consumption Value (2021-2032)
4.3 Europe Indocyanine Green for Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Indocyanine Green for Injection Consumption Value (2021-2032)
4.5 South America Indocyanine Green for Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Indocyanine Green for Injection Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
5.2 Global Indocyanine Green for Injection Consumption Value by Type (2021-2032)
5.3 Global Indocyanine Green for Injection Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
6.2 Global Indocyanine Green for Injection Consumption Value by Application (2021-2032)
6.3 Global Indocyanine Green for Injection Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
7.2 North America Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
7.3 North America Indocyanine Green for Injection Market Size by Country
7.3.1 North America Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
7.3.2 North America Indocyanine Green for Injection Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
8.2 Europe Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
8.3 Europe Indocyanine Green for Injection Market Size by Country
8.3.1 Europe Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
8.3.2 Europe Indocyanine Green for Injection Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Indocyanine Green for Injection Market Size by Region
9.3.1 Asia-Pacific Indocyanine Green for Injection Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Indocyanine Green for Injection Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
10.2 South America Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
10.3 South America Indocyanine Green for Injection Market Size by Country
10.3.1 South America Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
10.3.2 South America Indocyanine Green for Injection Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Indocyanine Green for Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Indocyanine Green for Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Indocyanine Green for Injection Market Size by Country
11.3.1 Middle East & Africa Indocyanine Green for Injection Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Indocyanine Green for Injection Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Indocyanine Green for Injection Market Drivers
12.2 Indocyanine Green for Injection Market Restraints
12.3 Indocyanine Green for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Indocyanine Green for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Indocyanine Green for Injection
13.3 Indocyanine Green for Injection Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Indocyanine Green for Injection Typical Distributors
14.3 Indocyanine Green for Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Indocyanine Green for Injection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Indocyanine Green for Injection Consumption Value by End-use Department, (USD Million), 2021 & 2025 & 2032
Table 3. Global Indocyanine Green for Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Diagnostic Green Basic Information, Manufacturing Base and Competitors
Table 5. Diagnostic Green Major Business
Table 6. Diagnostic Green Indocyanine Green for Injection Product and Services
Table 7. Diagnostic Green Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Diagnostic Green Recent Developments/Updates
Table 9. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 10. Daiichi Sankyo Major Business
Table 11. Daiichi Sankyo Indocyanine Green for Injection Product and Services
Table 12. Daiichi Sankyo Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Daiichi Sankyo Recent Developments/Updates
Table 14. Nanjing Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Nanjing Chia Tai Tianqing Pharmaceutical Major Business
Table 16. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
Table 17. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 19. Dandong Yichuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Dandong Yichuang Pharmaceutical Major Business
Table 21. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
Table 22. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Dandong Yichuang Pharmaceutical Recent Developments/Updates
Table 24. Global Indocyanine Green for Injection Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 25. Global Indocyanine Green for Injection Revenue by Manufacturer (2021-2026) & (USD Million)
Table 26. Global Indocyanine Green for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 27. Market Position of Manufacturers in Indocyanine Green for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 28. Head Office and Indocyanine Green for Injection Production Site of Key Manufacturer
Table 29. Indocyanine Green for Injection Market: Company Product Type Footprint
Table 30. Indocyanine Green for Injection Market: Company Product Application Footprint
Table 31. Indocyanine Green for Injection New Market Entrants and Barriers to Market Entry
Table 32. Indocyanine Green for Injection Mergers, Acquisition, Agreements, and Collaborations
Table 33. Global Indocyanine Green for Injection Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 34. Global Indocyanine Green for Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 35. Global Indocyanine Green for Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 36. Global Indocyanine Green for Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 37. Global Indocyanine Green for Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 38. Global Indocyanine Green for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 39. Global Indocyanine Green for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 40. Global Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 41. Global Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 42. Global Indocyanine Green for Injection Consumption Value by Type (2021-2026) & (USD Million)
Table 43. Global Indocyanine Green for Injection Consumption Value by Type (2027-2032) & (USD Million)
Table 44. Global Indocyanine Green for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 45. Global Indocyanine Green for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 46. Global Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 47. Global Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 48. Global Indocyanine Green for Injection Consumption Value by Application (2021-2026) & (USD Million)
Table 49. Global Indocyanine Green for Injection Consumption Value by Application (2027-2032) & (USD Million)
Table 50. Global Indocyanine Green for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 51. Global Indocyanine Green for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 52. North America Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 53. North America Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 54. North America Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 55. North America Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 56. North America Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 57. North America Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 58. North America Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 59. North America Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 60. Europe Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 61. Europe Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 62. Europe Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 63. Europe Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 64. Europe Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 65. Europe Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 66. Europe Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 67. Europe Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 68. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 69. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 70. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 71. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 72. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 73. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 74. Asia-Pacific Indocyanine Green for Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Indocyanine Green for Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 77. South America Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 78. South America Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 79. South America Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 80. South America Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 81. South America Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 82. South America Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 83. South America Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 85. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 86. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 87. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 88. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 89. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 90. Middle East & Africa Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Middle East & Africa Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Indocyanine Green for Injection Raw Material
Table 93. Key Manufacturers of Indocyanine Green for Injection Raw Materials
Table 94. Indocyanine Green for Injection Typical Distributors
Table 95. Indocyanine Green for Injection Typical Customers
Table 1. Global Indocyanine Green for Injection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Indocyanine Green for Injection Consumption Value by End-use Department, (USD Million), 2021 & 2025 & 2032
Table 3. Global Indocyanine Green for Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Diagnostic Green Basic Information, Manufacturing Base and Competitors
Table 5. Diagnostic Green Major Business
Table 6. Diagnostic Green Indocyanine Green for Injection Product and Services
Table 7. Diagnostic Green Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Diagnostic Green Recent Developments/Updates
Table 9. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 10. Daiichi Sankyo Major Business
Table 11. Daiichi Sankyo Indocyanine Green for Injection Product and Services
Table 12. Daiichi Sankyo Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Daiichi Sankyo Recent Developments/Updates
Table 14. Nanjing Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Nanjing Chia Tai Tianqing Pharmaceutical Major Business
Table 16. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
Table 17. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 19. Dandong Yichuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Dandong Yichuang Pharmaceutical Major Business
Table 21. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
Table 22. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Dandong Yichuang Pharmaceutical Recent Developments/Updates
Table 24. Global Indocyanine Green for Injection Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 25. Global Indocyanine Green for Injection Revenue by Manufacturer (2021-2026) & (USD Million)
Table 26. Global Indocyanine Green for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 27. Market Position of Manufacturers in Indocyanine Green for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 28. Head Office and Indocyanine Green for Injection Production Site of Key Manufacturer
Table 29. Indocyanine Green for Injection Market: Company Product Type Footprint
Table 30. Indocyanine Green for Injection Market: Company Product Application Footprint
Table 31. Indocyanine Green for Injection New Market Entrants and Barriers to Market Entry
Table 32. Indocyanine Green for Injection Mergers, Acquisition, Agreements, and Collaborations
Table 33. Global Indocyanine Green for Injection Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 34. Global Indocyanine Green for Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 35. Global Indocyanine Green for Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 36. Global Indocyanine Green for Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 37. Global Indocyanine Green for Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 38. Global Indocyanine Green for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 39. Global Indocyanine Green for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 40. Global Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 41. Global Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 42. Global Indocyanine Green for Injection Consumption Value by Type (2021-2026) & (USD Million)
Table 43. Global Indocyanine Green for Injection Consumption Value by Type (2027-2032) & (USD Million)
Table 44. Global Indocyanine Green for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 45. Global Indocyanine Green for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 46. Global Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 47. Global Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 48. Global Indocyanine Green for Injection Consumption Value by Application (2021-2026) & (USD Million)
Table 49. Global Indocyanine Green for Injection Consumption Value by Application (2027-2032) & (USD Million)
Table 50. Global Indocyanine Green for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 51. Global Indocyanine Green for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 52. North America Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 53. North America Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 54. North America Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 55. North America Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 56. North America Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 57. North America Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 58. North America Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 59. North America Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 60. Europe Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 61. Europe Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 62. Europe Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 63. Europe Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 64. Europe Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 65. Europe Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 66. Europe Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 67. Europe Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 68. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 69. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 70. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 71. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 72. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 73. Asia-Pacific Indocyanine Green for Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 74. Asia-Pacific Indocyanine Green for Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Indocyanine Green for Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 77. South America Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 78. South America Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 79. South America Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 80. South America Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 81. South America Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 82. South America Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 83. South America Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 85. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 86. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 87. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 88. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 89. Middle East & Africa Indocyanine Green for Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 90. Middle East & Africa Indocyanine Green for Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Middle East & Africa Indocyanine Green for Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Indocyanine Green for Injection Raw Material
Table 93. Key Manufacturers of Indocyanine Green for Injection Raw Materials
Table 94. Indocyanine Green for Injection Typical Distributors
Table 95. Indocyanine Green for Injection Typical Customers
LIST OF FIGURES
Figure 1. Indocyanine Green for Injection Picture
Figure 2. Global Indocyanine Green for Injection Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Indocyanine Green for Injection Revenue Market Share by Type in 2025
Figure 4. 25 mg/Vial Examples
Figure 5. 50 mg/Vial Examples
Figure 6. Global Indocyanine Green for Injection Revenue by End-use Department, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Indocyanine Green for Injection Revenue Market Share by End-use Department in 2025
Figure 8. Hepatobiliary and Gastrointestinal Surgery Examples
Figure 9. Oncology Surgery Examples
Figure 10. Vascular and Transplant Surgery Examples
Figure 11. Ophthalmology Examples
Figure 12. Others Examples
Figure 13. Global Indocyanine Green for Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Indocyanine Green for Injection Revenue Market Share by Application in 2025
Figure 15. Hospitals Examples
Figure 16. Specialty Clinics Examples
Figure 17. Other Examples
Figure 18. Global Indocyanine Green for Injection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Indocyanine Green for Injection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Indocyanine Green for Injection Sales Quantity (2021-2032) & (K Units)
Figure 21. Global Indocyanine Green for Injection Price (2021-2032) & (US$/Unit)
Figure 22. Global Indocyanine Green for Injection Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global Indocyanine Green for Injection Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of Indocyanine Green for Injection by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 Indocyanine Green for Injection Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 Indocyanine Green for Injection Manufacturer (Revenue) Market Share in 2025
Figure 27. Global Indocyanine Green for Injection Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global Indocyanine Green for Injection Consumption Value Market Share by Region (2021-2032)
Figure 29. North America Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 34. Global Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global Indocyanine Green for Injection Consumption Value Market Share by Type (2021-2032)
Figure 36. Global Indocyanine Green for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global Indocyanine Green for Injection Revenue Market Share by Application (2021-2032)
Figure 39. Global Indocyanine Green for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 52. France Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Indocyanine Green for Injection Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific Indocyanine Green for Injection Consumption Value Market Share by Region (2021-2032)
Figure 60. China Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 63. India Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 80. Indocyanine Green for Injection Market Drivers
Figure 81. Indocyanine Green for Injection Market Restraints
Figure 82. Indocyanine Green for Injection Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Indocyanine Green for Injection in 2025
Figure 85. Manufacturing Process Analysis of Indocyanine Green for Injection
Figure 86. Indocyanine Green for Injection Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Figure 1. Indocyanine Green for Injection Picture
Figure 2. Global Indocyanine Green for Injection Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Indocyanine Green for Injection Revenue Market Share by Type in 2025
Figure 4. 25 mg/Vial Examples
Figure 5. 50 mg/Vial Examples
Figure 6. Global Indocyanine Green for Injection Revenue by End-use Department, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Indocyanine Green for Injection Revenue Market Share by End-use Department in 2025
Figure 8. Hepatobiliary and Gastrointestinal Surgery Examples
Figure 9. Oncology Surgery Examples
Figure 10. Vascular and Transplant Surgery Examples
Figure 11. Ophthalmology Examples
Figure 12. Others Examples
Figure 13. Global Indocyanine Green for Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Indocyanine Green for Injection Revenue Market Share by Application in 2025
Figure 15. Hospitals Examples
Figure 16. Specialty Clinics Examples
Figure 17. Other Examples
Figure 18. Global Indocyanine Green for Injection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Indocyanine Green for Injection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Indocyanine Green for Injection Sales Quantity (2021-2032) & (K Units)
Figure 21. Global Indocyanine Green for Injection Price (2021-2032) & (US$/Unit)
Figure 22. Global Indocyanine Green for Injection Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global Indocyanine Green for Injection Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of Indocyanine Green for Injection by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 Indocyanine Green for Injection Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 Indocyanine Green for Injection Manufacturer (Revenue) Market Share in 2025
Figure 27. Global Indocyanine Green for Injection Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global Indocyanine Green for Injection Consumption Value Market Share by Region (2021-2032)
Figure 29. North America Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 34. Global Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global Indocyanine Green for Injection Consumption Value Market Share by Type (2021-2032)
Figure 36. Global Indocyanine Green for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global Indocyanine Green for Injection Revenue Market Share by Application (2021-2032)
Figure 39. Global Indocyanine Green for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 52. France Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Indocyanine Green for Injection Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific Indocyanine Green for Injection Consumption Value Market Share by Region (2021-2032)
Figure 60. China Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 63. India Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Indocyanine Green for Injection Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Indocyanine Green for Injection Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Indocyanine Green for Injection Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa Indocyanine Green for Injection Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa Indocyanine Green for Injection Consumption Value (2021-2032) & (USD Million)
Figure 80. Indocyanine Green for Injection Market Drivers
Figure 81. Indocyanine Green for Injection Market Restraints
Figure 82. Indocyanine Green for Injection Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Indocyanine Green for Injection in 2025
Figure 85. Manufacturing Process Analysis of Indocyanine Green for Injection
Figure 86. Indocyanine Green for Injection Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
